The Conversation (0)
Johnson & Johnson (NYSE:JNJ) confirmed it has re-entered talks with Actelion “regarding a potential transaction.”
On December 21, 2016, Johnson & Johnson (NYSE:JNJ) confirmed it has re-entered talks with Actelion “regarding a potential transaction.”
According to the press release:
“There can be no assurance any transaction will result from these discussions. Johnson & Johnson does not intend to make any additional comments regarding these discussions unless and until it is appropriate to do so, or a formal agreement has been reached.”
Stay tuned to this developing story … and read the full press release here.